Pharmaco - Press Releases

Date	Title	Company
08-Dec-2022	SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus	SK pharmteco
08-Dec-2022	MetrioPharm Announces Topline Data of its Phase IIa Study of MP1032 in COVID-19 Patients	MetrioPharm AG
08-Dec-2022	Neuraxpharm expands into the Netherlands	Neuraxpharm
08-Dec-2022	Anjarium Biosciences appoints ex-Novartis gene therapy leader Otmane Boussif, DSc as Chief Technology Officer	Anjarium Biosciences
08-Dec-2022	BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis	Sciad Newswire
08-Dec-2022	Relief Therapeutics Announces Executive Leadership Team Changes	Relief Therapeutics Holding SA
08-Dec-2022	Biotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B with hyperimmunoglobulins	Biotest AG
06-Dec-2022	MorphoSys Out Licenses Pre-Clinical Oncology Program	MorphoSys AG
06-Dec-2022	Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing	Agency for Science, Technology and Research (A*STAR)
06-Dec-2022	Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials	Novotech Health Holdings Pte Ltd
06-Dec-2022	MHRA approves Adtralza®▼(tralokinumab) for the treatment of adolescent patients with moderate-to-severe atopic dermatitis, who are candidates for systemic therapy	LEO Pharma
06-Dec-2022	Coriolis Pharma Appoints Formulation and Drug Development Expert Bruce Kerwin to Scientific Advisory Board	Coriolis Pharma
06-Dec-2022	F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress	F-star Therapeutics
06-Dec-2022	Sernova Announces CEO Succession Plan and Expanded Management Team	Sernova Corp.
06-Dec-2022	Gerresheimer AG: Gerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth	Gerresheimer AG
06-Dec-2022	Coriolis Pharma Appoints Formulation and Drug Development Expert Bruce Kerwin to Scientific Advisory Board	B3C newswire
06-Dec-2022	Kinarus Therapeutics’ KIN001 Shows Strong Antiviral Activity Against SARS-CoV-2 Omicron Subvariants BA.2 and BA.5	Kinarus Therapeutics
06-Dec-2022	LEO Pharma announces positive phase 3 topline results from DELTA 1 trial with delgocitinib cream in adults with moderate to severe chronic hand eczema (CHE)	LEO Pharma
06-Dec-2022	The subscription period in AlzeCure Pharma AB's rights issue begins today and the CEO has participated in a company presentation and CEO interview with Erik Penser Bank	AlzeCure Pharma
06-Dec-2022	OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC	OKYO Pharma Limited